VERTEX PHARMACEUTICALS INCORPORATED

Estimates Revisions Vertex Pharmaceuticals Incorporated Sao Paulo

Stocks

VRTX34

BRVRTXBDR001

Pharmaceuticals

Delayed Sao Paulo 11:28:40 2026-09-09 EDT			5-day change	1st Jan Change
83.68 ^BRL	-85.56%		-4.83%	+6.95%

09-02	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
09-01	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

Turnover - Evolution of Analysts' Estimates

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

Data source: Vertex Pharmaceuticals Incorporated(VRTX)

EBIT - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Data source: Vertex Pharmaceuticals Incorporated(VRTX)

Cash or Net Debt - Evolution of Analysts' Estimates

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	AMGEN INC.
	NOVO NORDISK A/S
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.

See all sector revisions

Turnover

Earnings Per Share (EPS)

Data source: Vertex Pharmaceuticals Incorporated(VRTX)

EBIT

Dividend / Share (DPS)

Data source: Vertex Pharmaceuticals Incorporated(VRTX)

Cash or Net Debt

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
VRTX Stock
VRTX34 Stock
Consensus Vertex Pharmaceuticals Incorporated
Estimates Revisions

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!